Clinical Trial Update: METIMMOX: Colorectal Cancer METastasis - Shaping Anti-tumor IMMunity by OXaliplatin [Phase 2]

View source ↗

Summary

Phase 2 study of METIMMOX for metastatic colorectal cancer completed with results posted. The study investigates leveraging oxaliplatin to shape anti-tumor immu…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Colorectal Cancer

Drugs mentioned

• METIMMOX
• OXALIPLATIN (Oxaliplatin)

Snippet

Sponsor: University Hospital, Akershus | Conditions: Colorectal Cancer Metastatic | Phase 2 | Status: COMPLETED | Results posted: 2026-02-13